ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Prostaglandin I2 Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-32O13807
Home | Market Reports | Health| Pharmacy
Global Prostaglandin I2 Market Research Report 2023
BUY CHAPTERS

Global Prostaglandin I2 Market Research Report 2025

Code: QYRE-Auto-32O13807
Report
May 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
United Therapeutics
J & J
GSK
Toray
Tide Pharma
Bayer
TEVA

Prostaglandin I2 Market Size

The global market for Prostaglandin I2 was valued at US$ 2760 million in the year 2024 and is projected to reach a revised size of US$ 4208 million by 2031, growing at a CAGR of 6.3% during the forecast period.

Prostaglandin I2 Market

Prostaglandin I2 Market

Prostaglandin I2 (PGI), or prostacyclin, is one of the prostanoids, a group of local hormones that are best known for their roles in mediating inflammation.
The prostaglandin I2 (PGI2) market is driven by its critical role as a potent vasodilator and inhibitor of platelet aggregation, making it an essential therapeutic option for various cardiovascular conditions. PGI2, also known as prostacyclin, is used to treat pulmonary arterial hypertension (PAH), preventing blood clot formation and improving blood flow in affected patients. The increasing prevalence of PAH and the growing awareness of its therapeutic benefits contribute to market growth. Moreover, advancements in pharmaceutical research and biotechnology have led to the development of new formulations and delivery methods for PGI2, further expanding its application in cardiovascular medicine. However, the market also faces challenges, including the high cost of PGI2 therapy, which may limit patient access and affordability. Additionally, the need for continuous infusion in some cases and potential side effects, such as bleeding complications, can pose obstacles for widespread adoption. To succeed in this market, manufacturers must focus on cost-effectiveness, patient-friendly administration methods, and conducting extensive clinical trials to establish the safety and efficacy of PGI2 therapies for various cardiovascular conditions, ensuring its continued use as a critical treatment option.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prostaglandin I2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostaglandin I2.
The Prostaglandin I2 market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostaglandin I2 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostaglandin I2 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Prostaglandin I2 Market Report

Report Metric Details
Report Name Prostaglandin I2 Market
Accounted market size in year US$ 2760 million
Forecasted market size in 2031 US$ 4208 million
CAGR 6.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • For Injection
  • For Oral
  • For Inhalation
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company United Therapeutics, J & J, GSK, Teva, Toray, Tide Pharma, Bayer AG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Prostaglandin I2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Prostaglandin I2 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Prostaglandin I2 Market growing?

Ans: The Prostaglandin I2 Market witnessing a CAGR of 6.3% during the forecast period 2025-2031.

What is the Prostaglandin I2 Market size in 2031?

Ans: The Prostaglandin I2 Market size in 2031 will be US$ 4208 million.

Who are the main players in the Prostaglandin I2 Market report?

Ans: The main players in the Prostaglandin I2 Market are United Therapeutics, J & J, GSK, Teva, Toray, Tide Pharma, Bayer AG

What are the Application segmentation covered in the Prostaglandin I2 Market report?

Ans: The Applications covered in the Prostaglandin I2 Market report are For Injection, For Oral, For Inhalation

What are the Type segmentation covered in the Prostaglandin I2 Market report?

Ans: The Types covered in the Prostaglandin I2 Market report are Epoprostenol Sodium, Treprostinil, Iloprost, Beraprost Sodium

Recommended Reports

Cardiovascular Drugs

Pulmonary Treatments

API and Related Markets

1 Prostaglandin I2 Market Overview
1.1 Product Definition
1.2 Prostaglandin I2 by Type
1.2.1 Global Prostaglandin I2 Market Value Comparison by Type (2024 VS 2031)
1.2.2 Epoprostenol Sodium
1.2.3 Treprostinil
1.2.4 Iloprost
1.2.5 Beraprost Sodium
1.3 Prostaglandin I2 by Application
1.3.1 Global Prostaglandin I2 Market Value by Application (2024 VS 2031)
1.3.2 For Injection
1.3.3 For Oral
1.3.4 For Inhalation
1.4 Global Prostaglandin I2 Market Size Estimates and Forecasts
1.4.1 Global Prostaglandin I2 Revenue 2020-2031
1.4.2 Global Prostaglandin I2 Sales 2020-2031
1.4.3 Global Prostaglandin I2 Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Prostaglandin I2 Market Competition by Manufacturers
2.1 Global Prostaglandin I2 Sales Market Share by Manufacturers (2020-2025)
2.2 Global Prostaglandin I2 Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Prostaglandin I2 Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Prostaglandin I2, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prostaglandin I2, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prostaglandin I2, Product Type & Application
2.7 Global Key Manufacturers of Prostaglandin I2, Date of Enter into This Industry
2.8 Global Prostaglandin I2 Market Competitive Situation and Trends
2.8.1 Global Prostaglandin I2 Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Prostaglandin I2 Players Market Share by Revenue
2.8.3 Global Prostaglandin I2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Prostaglandin I2 Market Scenario by Region
3.1 Global Prostaglandin I2 Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Prostaglandin I2 Sales by Region: 2020-2031
3.2.1 Global Prostaglandin I2 Sales by Region: 2020-2025
3.2.2 Global Prostaglandin I2 Sales by Region: 2026-2031
3.3 Global Prostaglandin I2 Revenue by Region: 2020-2031
3.3.1 Global Prostaglandin I2 Revenue by Region: 2020-2025
3.3.2 Global Prostaglandin I2 Revenue by Region: 2026-2031
3.4 North America Prostaglandin I2 Market Facts & Figures by Country
3.4.1 North America Prostaglandin I2 Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Prostaglandin I2 Sales by Country (2020-2031)
3.4.3 North America Prostaglandin I2 Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Prostaglandin I2 Market Facts & Figures by Country
3.5.1 Europe Prostaglandin I2 Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Prostaglandin I2 Sales by Country (2020-2031)
3.5.3 Europe Prostaglandin I2 Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prostaglandin I2 Market Facts & Figures by Region
3.6.1 Asia Pacific Prostaglandin I2 Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Prostaglandin I2 Sales by Region (2020-2031)
3.6.3 Asia Pacific Prostaglandin I2 Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Prostaglandin I2 Market Facts & Figures by Country
3.7.1 Latin America Prostaglandin I2 Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Prostaglandin I2 Sales by Country (2020-2031)
3.7.3 Latin America Prostaglandin I2 Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prostaglandin I2 Market Facts & Figures by Country
3.8.1 Middle East and Africa Prostaglandin I2 Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Prostaglandin I2 Sales by Country (2020-2031)
3.8.3 Middle East and Africa Prostaglandin I2 Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prostaglandin I2 Sales by Type (2020-2031)
4.1.1 Global Prostaglandin I2 Sales by Type (2020-2025)
4.1.2 Global Prostaglandin I2 Sales by Type (2026-2031)
4.1.3 Global Prostaglandin I2 Sales Market Share by Type (2020-2031)
4.2 Global Prostaglandin I2 Revenue by Type (2020-2031)
4.2.1 Global Prostaglandin I2 Revenue by Type (2020-2025)
4.2.2 Global Prostaglandin I2 Revenue by Type (2026-2031)
4.2.3 Global Prostaglandin I2 Revenue Market Share by Type (2020-2031)
4.3 Global Prostaglandin I2 Price by Type (2020-2031)
5 Segment by Application
5.1 Global Prostaglandin I2 Sales by Application (2020-2031)
5.1.1 Global Prostaglandin I2 Sales by Application (2020-2025)
5.1.2 Global Prostaglandin I2 Sales by Application (2026-2031)
5.1.3 Global Prostaglandin I2 Sales Market Share by Application (2020-2031)
5.2 Global Prostaglandin I2 Revenue by Application (2020-2031)
5.2.1 Global Prostaglandin I2 Revenue by Application (2020-2025)
5.2.2 Global Prostaglandin I2 Revenue by Application (2026-2031)
5.2.3 Global Prostaglandin I2 Revenue Market Share by Application (2020-2031)
5.3 Global Prostaglandin I2 Price by Application (2020-2031)
6 Key Companies Profiled
6.1 United Therapeutics
6.1.1 United Therapeutics Company Information
6.1.2 United Therapeutics Description and Business Overview
6.1.3 United Therapeutics Prostaglandin I2 Sales, Revenue and Gross Margin (2020-2025)
6.1.4 United Therapeutics Prostaglandin I2 Product Portfolio
6.1.5 United Therapeutics Recent Developments/Updates
6.2 J & J
6.2.1 J & J Company Information
6.2.2 J & J Description and Business Overview
6.2.3 J & J Prostaglandin I2 Sales, Revenue and Gross Margin (2020-2025)
6.2.4 J & J Prostaglandin I2 Product Portfolio
6.2.5 J & J Recent Developments/Updates
6.3 GSK
6.3.1 GSK Company Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Prostaglandin I2 Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GSK Prostaglandin I2 Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Teva
6.4.1 Teva Company Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Prostaglandin I2 Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Teva Prostaglandin I2 Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Toray
6.5.1 Toray Company Information
6.5.2 Toray Description and Business Overview
6.5.3 Toray Prostaglandin I2 Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Toray Prostaglandin I2 Product Portfolio
6.5.5 Toray Recent Developments/Updates
6.6 Tide Pharma
6.6.1 Tide Pharma Company Information
6.6.2 Tide Pharma Description and Business Overview
6.6.3 Tide Pharma Prostaglandin I2 Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Tide Pharma Prostaglandin I2 Product Portfolio
6.6.5 Tide Pharma Recent Developments/Updates
6.7 Bayer AG
6.7.1 Bayer AG Company Information
6.7.2 Bayer AG Description and Business Overview
6.7.3 Bayer AG Prostaglandin I2 Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bayer AG Prostaglandin I2 Product Portfolio
6.7.5 Bayer AG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prostaglandin I2 Industry Chain Analysis
7.2 Prostaglandin I2 Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prostaglandin I2 Production Mode & Process Analysis
7.4 Prostaglandin I2 Sales and Marketing
7.4.1 Prostaglandin I2 Sales Channels
7.4.2 Prostaglandin I2 Distributors
7.5 Prostaglandin I2 Customer Analysis
8 Prostaglandin I2 Market Dynamics
8.1 Prostaglandin I2 Industry Trends
8.2 Prostaglandin I2 Market Drivers
8.3 Prostaglandin I2 Market Challenges
8.4 Prostaglandin I2 Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
United Therapeutics
J & J
GSK
Toray
Tide Pharma
Bayer
TEVA
List of Tables
 Table 1. Global Prostaglandin I2 Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Prostaglandin I2 Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Prostaglandin I2 Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Prostaglandin I2 Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Prostaglandin I2 Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Prostaglandin I2 Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Prostaglandin I2 Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Prostaglandin I2 Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Prostaglandin I2, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Prostaglandin I2, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Prostaglandin I2, Product Type & Application
 Table 12. Global Key Manufacturers of Prostaglandin I2, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Prostaglandin I2 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostaglandin I2 as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Prostaglandin I2 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Prostaglandin I2 Sales by Region (2020-2025) & (K Units)
 Table 18. Global Prostaglandin I2 Sales Market Share by Region (2020-2025)
 Table 19. Global Prostaglandin I2 Sales by Region (2026-2031) & (K Units)
 Table 20. Global Prostaglandin I2 Sales Market Share by Region (2026-2031)
 Table 21. Global Prostaglandin I2 Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Prostaglandin I2 Revenue Market Share by Region (2020-2025)
 Table 23. Global Prostaglandin I2 Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Prostaglandin I2 Revenue Market Share by Region (2026-2031)
 Table 25. North America Prostaglandin I2 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Prostaglandin I2 Sales by Country (2020-2025) & (K Units)
 Table 27. North America Prostaglandin I2 Sales by Country (2026-2031) & (K Units)
 Table 28. North America Prostaglandin I2 Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Prostaglandin I2 Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Prostaglandin I2 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Prostaglandin I2 Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Prostaglandin I2 Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Prostaglandin I2 Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Prostaglandin I2 Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Prostaglandin I2 Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Prostaglandin I2 Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Prostaglandin I2 Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Prostaglandin I2 Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Prostaglandin I2 Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Prostaglandin I2 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Prostaglandin I2 Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Prostaglandin I2 Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Prostaglandin I2 Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Prostaglandin I2 Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Prostaglandin I2 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Prostaglandin I2 Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Prostaglandin I2 Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Prostaglandin I2 Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Prostaglandin I2 Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Prostaglandin I2 Sales (K Units) by Type (2020-2025)
 Table 51. Global Prostaglandin I2 Sales (K Units) by Type (2026-2031)
 Table 52. Global Prostaglandin I2 Sales Market Share by Type (2020-2025)
 Table 53. Global Prostaglandin I2 Sales Market Share by Type (2026-2031)
 Table 54. Global Prostaglandin I2 Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Prostaglandin I2 Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Prostaglandin I2 Revenue Market Share by Type (2020-2025)
 Table 57. Global Prostaglandin I2 Revenue Market Share by Type (2026-2031)
 Table 58. Global Prostaglandin I2 Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Prostaglandin I2 Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Prostaglandin I2 Sales (K Units) by Application (2020-2025)
 Table 61. Global Prostaglandin I2 Sales (K Units) by Application (2026-2031)
 Table 62. Global Prostaglandin I2 Sales Market Share by Application (2020-2025)
 Table 63. Global Prostaglandin I2 Sales Market Share by Application (2026-2031)
 Table 64. Global Prostaglandin I2 Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Prostaglandin I2 Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Prostaglandin I2 Revenue Market Share by Application (2020-2025)
 Table 67. Global Prostaglandin I2 Revenue Market Share by Application (2026-2031)
 Table 68. Global Prostaglandin I2 Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Prostaglandin I2 Price (US$/Unit) by Application (2026-2031)
 Table 70. United Therapeutics Company Information
 Table 71. United Therapeutics Description and Business Overview
 Table 72. United Therapeutics Prostaglandin I2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. United Therapeutics Prostaglandin I2 Product
 Table 74. United Therapeutics Recent Developments/Updates
 Table 75. J & J Company Information
 Table 76. J & J Description and Business Overview
 Table 77. J & J Prostaglandin I2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. J & J Prostaglandin I2 Product
 Table 79. J & J Recent Developments/Updates
 Table 80. GSK Company Information
 Table 81. GSK Description and Business Overview
 Table 82. GSK Prostaglandin I2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. GSK Prostaglandin I2 Product
 Table 84. GSK Recent Developments/Updates
 Table 85. Teva Company Information
 Table 86. Teva Description and Business Overview
 Table 87. Teva Prostaglandin I2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Teva Prostaglandin I2 Product
 Table 89. Teva Recent Developments/Updates
 Table 90. Toray Company Information
 Table 91. Toray Description and Business Overview
 Table 92. Toray Prostaglandin I2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Toray Prostaglandin I2 Product
 Table 94. Toray Recent Developments/Updates
 Table 95. Tide Pharma Company Information
 Table 96. Tide Pharma Description and Business Overview
 Table 97. Tide Pharma Prostaglandin I2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Tide Pharma Prostaglandin I2 Product
 Table 99. Tide Pharma Recent Developments/Updates
 Table 100. Bayer AG Company Information
 Table 101. Bayer AG Description and Business Overview
 Table 102. Bayer AG Prostaglandin I2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Bayer AG Prostaglandin I2 Product
 Table 104. Bayer AG Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Prostaglandin I2 Distributors List
 Table 108. Prostaglandin I2 Customers List
 Table 109. Prostaglandin I2 Market Trends
 Table 110. Prostaglandin I2 Market Drivers
 Table 111. Prostaglandin I2 Market Challenges
 Table 112. Prostaglandin I2 Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Prostaglandin I2
 Figure 2. Global Prostaglandin I2 Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Prostaglandin I2 Market Share by Type: 2024 & 2031
 Figure 4. Epoprostenol Sodium Product Picture
 Figure 5. Treprostinil Product Picture
 Figure 6. Iloprost Product Picture
 Figure 7. Beraprost Sodium Product Picture
 Figure 8. Global Prostaglandin I2 Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Prostaglandin I2 Market Share by Application: 2024 & 2031
 Figure 10. For Injection
 Figure 11. For Oral
 Figure 12. For Inhalation
 Figure 13. Global Prostaglandin I2 Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Prostaglandin I2 Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Prostaglandin I2 Sales (2020-2031) & (K Units)
 Figure 16. Global Prostaglandin I2 Average Price (US$/Unit) & (2020-2031)
 Figure 17. Prostaglandin I2 Report Years Considered
 Figure 18. Prostaglandin I2 Sales Share by Manufacturers in 2024
 Figure 19. Global Prostaglandin I2 Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Prostaglandin I2 Players: Market Share by Revenue in Prostaglandin I2 in 2024
 Figure 21. Prostaglandin I2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Prostaglandin I2 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Prostaglandin I2 Sales Market Share by Country (2020-2031)
 Figure 24. North America Prostaglandin I2 Revenue Market Share by Country (2020-2031)
 Figure 25. United States Prostaglandin I2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Prostaglandin I2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Prostaglandin I2 Sales Market Share by Country (2020-2031)
 Figure 28. Europe Prostaglandin I2 Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Prostaglandin I2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Prostaglandin I2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Prostaglandin I2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Prostaglandin I2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Prostaglandin I2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Prostaglandin I2 Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Prostaglandin I2 Revenue Market Share by Region (2020-2031)
 Figure 36. China Prostaglandin I2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Prostaglandin I2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Prostaglandin I2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Prostaglandin I2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Prostaglandin I2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Prostaglandin I2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Prostaglandin I2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Prostaglandin I2 Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Prostaglandin I2 Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Prostaglandin I2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Prostaglandin I2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Prostaglandin I2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Prostaglandin I2 Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Prostaglandin I2 Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Prostaglandin I2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Prostaglandin I2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Prostaglandin I2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Prostaglandin I2 by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Prostaglandin I2 by Type (2020-2031)
 Figure 55. Global Prostaglandin I2 Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Prostaglandin I2 by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Prostaglandin I2 by Application (2020-2031)
 Figure 58. Global Prostaglandin I2 Price (US$/Unit) by Application (2020-2031)
 Figure 59. Prostaglandin I2 Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Prostacyclin Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global PG Hormone Market Research Report 2025
Prostaglandins and Related Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prostacyclin Market Research Report 2025
Global Prostaglandin E2 Market Research Report 2025
Global Indomethacin Tablets Market Research Report 2024
Global Indometacin Indomethacin Market Research Report 2024
Propylene Glycol Industrial PGI Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prostaglandin Market Research Report 2025
Global Prostaglandin D2 Receptor 2 Market Research Report 2025
Global Indomethacin Market Research Report 2024
Global Cyclooxygenase 2 Inhibitor Market Research Report 2024
Global Prostaglandin endoperoxide Synthase 2 COX 2 Protein Market Research Report 2024
Global Prostaglandin endoperoxide Synthase 2 COX 2 Antibody Market Research Report 2024
Global Tafluprost Market Insights Forecast to 2030
Cox 2 Inhibitors Market
Global Specific COX 2 Inhibitors Market Research Report 2024
Global Iloprost Drugs Market Insights Forecast to 2030
Global Epoprostenol Sodium Drugs Market Insights Forecast to 2030
Global Cyclooxygenase 2 Inhibitor COVID 19 Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions